Pharma-Bio Serv to Present at Sidoti's Eighth Semi-Annual New York Micro-Cap Conference
10 Janeiro 2014 - 7:37PM
Marketwired
Pharma-Bio Serv to Present at Sidoti's Eighth Semi-Annual New York
Micro-Cap Conference
DORADO, PR--(Marketwired - Jan 10, 2014) - Pharma-Bio Serv
(OTCQB: PBSV), a global compliance and validation services
consulting solutions provider, announced today that it will be
presenting at Sidoti & Company's Eighth Semi-Annual Micro-Cap
Conference on Monday, January 13, 2014 at 8:00 am at the Grand
Hyatt New York Hotel in midtown Manhattan.
About Pharma-Bio Serv Inc.
Pharma-Bio Serv is a global compliance and validation services
consulting solutions provider, headquartered in Puerto Rico, with
operations in the U.S., Ireland and Spain. Pharma-Bio Serv's core
business is FDA and international agencies regulatory compliance
related services with integrated portfolio services including
microbiological and chemical testing services for clients in the
Pharmaceutical, Biotechnology, Chemical, Medical Device, Cosmetic,
Food and Allied Products industries, at its laboratory testing
facility in Puerto Rico. Services also include "Integratek," an
information technology consulting practice and "Pharma Serv
Academy" a division that provides technical and regulatory
standards seminars/training conducted by industry experts. The
Company's global team includes more than 285 leading engineering
and life science professionals, quality assurance managers and
directors.
About Sidoti & Company, LLC
Sidoti & Company, LLC, founded in 1999, continues to set the
Wall Street standard for independent small-cap equity research,
while rapidly becoming a driving force in micro-cap research,
launching coverage of more than 400 equities of $250 million market
cap or less since mid-2010. Its analysts mine dozens of industries
to provide unbiased, institutional-quality research focusing on the
investment merits of profitable companies at a sub-$3 billion
market cap, and it continues to expand its coverage of micro-cap
equities.
Forward-Looking Statements
This news release and the presentation contain "forward-looking
statements" within the meaning of the U.S. federal securities laws,
which statements may include information regarding the plans,
intentions, expectations, future financial performance, or future
operating performance of Pharma-Bio Serv. Forward-looking
statements are based on the expectations, estimates, or projections
of management as of the date of this news release. Although
Pharma-Bio Serv's management believes these expectations,
estimates, or projections to be reasonable as of the date of this
news release, forward-looking statements are inherently subject to
significant business risks, economic and competitive uncertainties,
or other contingencies, which could cause its actual results or
performance to differ materially from what may be expressed or
implied in the forward-looking statements. Important factors that
could cause Pharma-Bio Serv's actual results or performance to
differ materially from the forward-looking statements include those
set forth in the "Risk Factors" section of Pharma-Bio Serv's Annual
Report on Form 10-K for the year ended October 31, 2012 and in its
other filings with the Securities and Exchange Commission, which
filings are available on www.sec.gov. Pharma-Bio Serv disclaims any
intention or obligation to update or revise any forward-looking
statements to reflect subsequent events and circumstances, except
to the extent required by applicable law.
Investor Relations Contact: Scott Gordon President CorProminence
LLC scottg@corprominence.com 631 703 4900
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024